Ensong Guo
- Topics
- PARP inhibition in cancer therapy (3 papers)CRISPR and Genetic Engineering (2 papers)Cancer Immunotherapy and Biomarkers (2 papers)
- Partner nations
- ChinaNepalUnited States
In The Last Decade
Ensong Guo
9 papers receiving 310 citations
Peers
Comparison fields: 5 of 62
- Molecular Biology 220
- Oncology 91
- Immunology 62
- Reproductive Medicine 37
- Cancer Research 37
Countries citing papers authored by Ensong Guo
This map shows the geographic impact of Ensong Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ensong Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ensong Guo more than expected).
Fields of papers citing papers by Ensong Guo
This network shows the impact of papers produced by Ensong Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ensong Guo. The network helps show where Ensong Guo may publish in the future.
Co-authorship network of co-authors of Ensong Guo
This figure shows the co-authorship network connecting the top 25 collaborators of Ensong Guo. A scholar is included among the top collaborators of Ensong Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ensong Guo. Ensong Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 50 | |
| 3 | 38 | |
| 4 | 20 | |
| 5 | mTOR inhibition overcomes primary and acquired resistance to Wee1 inhibition by augmenting replication stress in epithelial ovarian cancers. | 14 |
| 6 | 15 | |
| 7 | 114 | |
| 8 | 24 | |
| 9 | 19 |
About Ensong Guo
Ensong Guo is a scholar working on Structural Biology, Toxicology and Oncology, having authored 9 papers that have together received 311 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (3 papers), CRISPR and Genetic Engineering (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Reproductive Medicine (37 citations), Microbiology (27 citations) and Oncology (91 citations). Ensong Guo has collaborated with scholars based in China, Nepal and United States. Frequent co-authors include Chaoyang Sun, Gang Chen, Jia Huang, Rourou Xiao, Junbo Hu, Meng Xia, Xiaoyan Xu, Hao Lü, Wanying Shan and Ding Ma. Their work appears in journals such as Cancer Research, Scientific Reports and Acta Biomaterialia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.